Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
CANC
56
HOLDINGS
20%
ALSO IN IDNA
IDNA
52
HOLDINGS
28%
ALSO IN CANC
SECTOR DRIFT (CANC minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 7.7% | 5.7% | 5.7% |
|
MERCK & CO. INC. | 3.9% | 4.2% | 3.9% |
|
EXELIXIS INC | 3.0% | 3.8% | 3.0% |
|
IDEAYA BIOSCIENCES, INC. | 2.2% | 3.5% | 2.2% |
|
ARCELLX, INC. | 2.2% | 3.2% | 2.2% |
CANC Overweight Relative to IDNA
 |
NOVARTIS AG | 4.6% |
|
ELI LILLY & CO | 4.6% |
 |
ASTRAZENECA PLC | 4.3% |
|
BRIDGEBIO PHARMA, INC. | 4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 4.0% |
 |
GENMAB A/S SPONSORED ADR | 3.8% |
|
BRISTOL-MYERS SQUIBB CO | 3.4% |
|
NUVALENT, INC. CLASS A | 3.2% |
|
COGENT BIOSCIENCES INC | 3.1% |
|
AMGEN INC | 2.7% |
CANC Underweight Relative to IDNA
|
MODERNA, INC. | -4.7% |
 |
BAYER AG | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.3% |
|
ROCHE HOLDING LTD | -4.2% |
|
GENMAB A/S | -4.1% |
|
GSK PLC | -4.0% |
 |
IPSEN | -4.0% |
|
INCYTE CORP | -4.0% |
|
BIONTECH SE SPONSORED ADR | -4.0% |
|
VERTEX PHARMACEUTICALS INC | -3.9% |